Submit Content
Sponsored in Part By
Sponsored
Lung Cancer - Chemotherapy
Thoracic
Nivolumab Plus Ipilimumab in Lung Cancer With a High Tumor Mutational Burden
By Mark Ferguson
Jun. 1, 2018
0
Thoracic
Pembrolizumab Plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
By Mark Ferguson
May. 31, 2018
0
Thoracic
Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base
By Mark Ferguson
Apr. 13, 2018
0
Valve Disease
In Global News: Weaving Devices for CHD by Hand, Sodas and CAD, and Rapid Deployment Versus Conventional Valves
By Grahame Rush
Mar. 30, 2018
0
Aorta
In Global News: Smallest Heart Valve for Infants, a Modified TAVR Valve for TMVR, and Thoracic Outlet Surgery Fashion
By Claire Vernon
Mar. 9, 2018
0
Thoracic
Lung Cancer Awareness Month—A Lot of Progress, But More Work Needs to Be Done
By Mark Ferguson
Oct. 24, 2017
0
Thoracic
Scientific Advances in Thoracic Oncology 2016
By Mark Ferguson
Aug. 2, 2017
0
Thoracic
The 5000% case: a glimpse into the financial issue of lung cancer treatment
By Marcelo Jimenez
May. 5, 2016
1
Thoracic
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
By Mark Ferguson
Sep. 12, 2015
0
Thoracic
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection
By Lisa Brown
May. 17, 2015
0
Thoracic
IBM’s Watson to Guide Cancer Therapies at 14 Centers
By Mark Ferguson
May. 8, 2015
0
Thoracic
Effect of Prior Cancer on Outcomes in Advanced Lung Cancer: Implications for Clinical Trial Eligibility and Accrual
By Marcelo Jimenez
Feb. 16, 2015
0
1 2 3

Log In

New to CTSNet? Sign Up

Forgot Password